12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

ProImmune sales and marketing update

ProImmune launched the ProStorm cytokine release assay service to assess the likelihood of first infusion reactions to novel therapeutics. The in vitro assay uses blood from 20-50 healthy volunteers to measure TNF...

Read the full 147 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >